BioNTech says ‘no evidence’ its jabs need adapting for variants
How proteins control information processing in the brain
10 May 2021Europe eases COVID-19 curbs as huge India outbreak persists
10 May 2021BioNTech says ‘no evidence’ its jabs need adapting for variants
German firm BioNTech said Monday that the COVID-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
